Health Ministry of Indonesia. Published 2020. Accessed March 30, 2020. https://covid19.go.id/
2.
Kementerian PPN/Bappenas. Isu-Isu Strategis Dan Agenda Pembangunan Rt Rpjmn 2020-2024. Kementerian PPN/Bappenas; 2019.
3.
Kementerian Kesehatan. Laporan Nasional Riset Kesehatan Dasar (Riskesdas) Indonesia Tahun 2018. Kementerian Kesehatan; 2018.
4.
ZhouFYuTDuR, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062. doi:10.1016/S0140-6736(20)30566-3
5.
MehraMRDesaiSSKuySHenryTDPatelAN. Cardiovascular disease, drug therapy, and mortality in COVID-19. N Engl J Med. 2020;382:e102. doi:10.1056/NEJMoa2007621
6.
ZhangJWangXJiaX, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020;26:767-772. doi:10.1016/j.cmi.2020.04.012
7.
DuRHLiangLRYangCQ, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020;55:2000524. doi:10.1183/13993003.00524-2020
8.
Martins-FilhoPRTavaresCSSSantosVS. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. Eur J Intern Med. 2020;76:97-99. doi:10.1016/j.ejim.2020.04.043
9.
TangWLiaoHMarleyG, et al. The changing pattern of COVID-19 in China: a tempogeographic analysis of the SARS-CoV-2 epidemic. Clin Infect Dis. 2020;71:818-824. doi:10.1093/cid/ciaa423
